Related Experiment Video
Updated: Feb 6, 2026

A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies
Published on: November 7, 2015
Gankyrin as a potential target for tumor therapy: evidence and perspectives
Haixai Li1, Junyan Zhang1, Cheng Zhen2
1Department of Obstetrics and Gynecology, Beijing Tiantan Hospital, Capital Medical University Beijing 100050, China.
Abstract:
Gankyrin (also known as PSMD10 or p28GANK), engages in diverse biological processes, including cellular growth, proliferation and invasion. Several studies have demonstrated that Gankyrin is a candidate oncogene. In parallel, the dysregulation of Gankyrin has been observered in a variety of human cancer. Overexpression of Gankyrin is involved in tumor initiation and progression by regulating several signaling pathways that control cell-cycle process, cell growth, apoptosis, et al. On the contrary, downregulation of Gankyrin significantly inhibits cell growth, proliferation and metastasis. Therefore, Gankyrin appears to be a potential target for tumor therapy. Herein, this review summarizes the current knowledge in understanding the biological functions and oncogenic role of Gankyrin in human cancers from the perspective of clinical-pathological significances, aiming to provide guidance for the development of Gankyrin-targeted therapy.
Insights
Gankyrin (PSMD10) is an oncogene implicated in various cancers. Its overexpression promotes tumor growth, while downregulation inhibits it, making Gankyrin a promising target for cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
Background:
- Gankyrin (PSMD10) is involved in cell growth, proliferation, and invasion.
- Gankyrin is recognized as a candidate oncogene with observed dysregulation in human cancers.
Purpose of the Study:
- To review the biological functions and oncogenic role of Gankyrin in human cancers.
- To explore the clinical-pathological significance of Gankyrin.
- To provide guidance for developing Gankyrin-targeted cancer therapies.
Main Methods:
- Literature review of existing studies on Gankyrin.
- Analysis of Gankyrin's role in various signaling pathways.
- Examination of clinical-pathological data related to Gankyrin expression.
Main Results:
- Gankyrin overexpression contributes to tumor initiation and progression.
- Gankyrin regulates key pathways controlling cell cycle, growth, and apoptosis.
- Downregulation of Gankyrin inhibits cancer cell growth, proliferation, and metastasis.
Conclusions:
- Gankyrin plays a significant role in human cancer development and progression.
- Gankyrin is a potential therapeutic target for various cancers.
- Further research into Gankyrin-targeted therapies is warranted.
Related Concept Videos
The Evidence for Evolution
Targeted Cancer Therapies
There are several types of targeted therapies against...
Psychodynamic Perspectives on Personality
Psychodynamic theorists argue that unconscious...
Criticisms of the Evolutionary Perspective
Evolutionary psychology provides one explanation for these findings, suggesting...
The Behavioral Perspective on Personality
Social Cognitive Perspective on Personality

